当前位置:首页 - 行情中心 - 易瑞生物(300942) - 财务分析 - 现金流量表

易瑞生物

(300942)

  

流通市值:31.96亿  总市值:31.96亿
流通股本:4.05亿   总股本:4.05亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金78,030,546.98288,107,810.78190,874,391.53117,461,879.85
  收到的税费返还-14,381.914,381.914,381.9
  收到其他与经营活动有关的现金3,169,030.1655,930,576.0115,396,217.7811,537,678.95
  经营活动现金流入小计81,199,577.14344,052,768.69206,284,991.21129,013,940.7
  购买商品、接受劳务支付的现金45,638,455.27126,468,276.3672,274,492.247,579,131.63
  支付给职工以及为职工支付的现金30,760,409.6793,427,919.8870,386,233.9248,033,025.33
  支付的各项税费1,385,421.916,364,879.762,384,748.321,680,684.62
  支付其他与经营活动有关的现金15,942,736.950,919,878.8553,410,540.4131,741,451.58
  经营活动现金流出小计93,727,023.75277,180,954.85198,456,014.85129,034,293.16
  经营活动产生的现金流量净额-12,527,446.6166,871,813.847,828,976.36-20,352.46
二、投资活动产生的现金流量:
  收回投资收到的现金12,590,898.3820,598,934.4820,598,934.48-
  取得投资收益收到的现金1,231,761.635,175,260.224,976,290.473,707,966.25
  处置固定资产、无形资产和其他长期资产收回的现金净额70,00029,177,317.5629,329,300.381,004,606.63
  处置子公司及其他营业单位收到的现金净额-359,143.42359,143.42359,143.42
  收到的其他与投资活动有关的现金96,740,505.48810,694,720.8686,213,774.35377,213,774.35
  投资活动现金流入小计110,633,165.49866,005,376.48741,477,443.1382,285,490.65
  购建固定资产、无形资产和其他长期资产支付的现金33,927,808.3645,899,685.4932,164,358.9820,543,108.91
  投资支付的现金017,000,0009,750,0007,150,000
  支付其他与投资活动有关的现金48,386,590.73764,596,157.31544,571,355.76229,571,355.76
  投资活动现金流出小计82,314,399.09827,495,842.8586,485,714.74257,264,464.67
  投资活动产生的现金流量净额28,318,766.438,509,533.68154,991,728.36125,021,025.98
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,005,000640,000240,000240,000
  其中:子公司吸收少数股东投资收到的现金3,005,000640,000240,000240,000
  取得借款收到的现金21,765,781.2826,688,827.6226,688,827.625,688,827.62
  收到其他与筹资活动有关的现金-0--
  筹资活动现金流入小计24,770,781.2827,328,827.6226,928,827.625,928,827.62
  偿还债务支付的现金13,217,227.0940,988,926.8438,541,695.1336,094,463.42
  分配股利、利润或偿付利息支付的现金1,904,705.3913,857,304.212,552,852.9910,035,189.93
  支付其他与筹资活动有关的现金-0--
  筹资活动现金流出小计15,121,932.4854,846,231.0451,094,548.1246,129,653.35
  筹资活动产生的现金流量净额9,648,848.8-27,517,403.42-24,165,720.5-40,200,825.73
四、汇率变动对现金及现金等价物的影响-6,680,492.72986,297.223,204,826.714,472,755.28
五、现金及现金等价物净增加额18,759,675.8778,850,241.32141,859,810.9389,272,603.07
  加:期初现金及现金等价物余额335,982,200.74257,131,959.42257,131,959.42257,131,959.42
  期末现金及现金等价物余额354,741,876.61335,982,200.74398,991,770.35346,404,562.49
补充资料:
  净利润-15,466,356.76-1,889,832.3
  资产减值准备-10,343,338.84-781,587.6
  固定资产和投资性房地产折旧-27,937,033.57-10,822,484.9
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-27,937,033.57-10,822,484.9
  无形资产摊销-1,941,548.19-970,565.76
  长期待摊费用摊销-705,773.71-493,641.32
  处置固定资产、无形资产和其他长期资产的损失--12,214,552.49--171,594.88
  固定资产报废损失--117,992.17--52,820.68
  公允价值变动损失--2,949,322.7--1,704,458.31
  财务费用-26,492,015.63-8,351,020.95
  投资损失-8,145,643.14-2,323,090.92
  递延所得税--6,967,616.7--1,245,548.37
  其中:递延所得税资产减少--6,967,616.7--1,245,548.37
  存货的减少--16,720,289.81--12,281,469.91
  经营性应收项目的减少--20,548,794.3-3,370,358.86
  经营性应付项目的增加-39,277,628.28--11,875,686.92
  其他--3,918,956.11--1,691,356
  现金的期末余额-335,982,200.74-346,404,562.49
  减:现金的期初余额-257,131,959.42-257,131,959.42
  现金及现金等价物的净增加额-78,850,241.32-89,272,603.07
公告日期2026-04-272026-04-272025-10-282025-08-28
审计意见(境内)标准无保留意见
TOP↑